Latest Articles
Global, regional, and national burdens of endometriosis from 1990 to 2021: a trend analysis.
Endometriosis is a common, chronic, estrogen-dependent gynecological disorder that significantly affects patients' quality of life. However, the disease burden and its trends may be undergoing significant changes, and comprehensive data …
Published: Aug. 14, 2025, midnight
Bindi Irwin Shares Her Hernia From Giving Birth Began "Unzipping" - E! Online
Bindi Irwin Shares Her Hernia From Giving Birth Began "Unzipping" E! Online
Published: Aug. 13, 2025, 11:43 p.m.
Bindi Irwin Shares Her Hernia From Giving Birth Was "Unzipping" Before Hospitalization - E! Online
Bindi Irwin Shares Her Hernia From Giving Birth Was "Unzipping" Before Hospitalization E! Online
Published: Aug. 13, 2025, 11:41 p.m.
GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight - The Malaysian Reserve
GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight The Malaysian Reserve
Published: Aug. 13, 2025, 10:08 p.m.
'13 years of fighting for answers': Bindi Irwin gives health update after undergoing emergency surgery in the US - 9Honey Celebrity
'13 years of fighting for answers': Bindi Irwin gives health update after undergoing emergency surgery in the US 9Honey Celebrity
Published: Aug. 13, 2025, 9:36 p.m.
GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight - PR Newswire UK
GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight PR Newswire UK
Published: Aug. 13, 2025, 9:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times
Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire
Published: Aug. 13, 2025, 8:17 p.m.
Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials - Stock Titan
Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials Stock Titan
Published: Aug. 13, 2025, 8:15 p.m.
GnRH Receptor Antagonists Market Poised for Significant - openPR.com
GnRH Receptor Antagonists Market Poised for Significant openPR.com
Published: Aug. 13, 2025, 7:52 p.m.
Link copied to clipboard!